远程重症监护介导的低表现患者诊断组死亡率下降:一项前瞻性前后对照研究
该前瞻性观察性前后对照研究在学术医学中心3个成人ICU中,比较远程重症监护(TCC)实施前后(2016年1-6月 vs 2017年1月-2019年6月)共2429例和12479例患者。TCC包含针对低表现患者组(TCC前APACHE诊断类别SMR>1.5)的 acuity 驱动工作流程。总体ICU人群SMR由0.83降至0.75,风险校正死亡率10.7% vs 9.5%(p=0.09)。低表现组(占TCC前12.6%、TCC后13.3%)SMR由1.61(95%CI 1.21-2.01)降至1.03(95%CI 0.91-1.15),风险校正死亡率由26.4%降至16.9%(p<0.001);高表现组无变化(SMR 0.70 vs 0.69,死亡率8.5% vs 8.4%,p=0.86)。两组标准化HLOS比值和风险校正HLOS均无前后差异。
要点
- 低表现患者组(TCC前APACHE诊断类别SMR>1.5)占TCC前12.6%(n=307)、TCC后13.3%(n=1671),风险校正死亡率由26.4%降至16.9%(p<0.001)。
- 低表现组SMR由TCC前1.61(95%CI 1.21-2.01)降至TCC后1.03(95%CI 0.91-1.15)。
- 高表现组SMR 0.70(95%CI 0.59-0.81)vs 0.69(95%CI 0.64-0.73),风险校正死亡率8.5% vs 8.4%(p=0.86),无变化。
- 总体ICU人群SMR 0.83 vs 0.75,风险校正死亡率10.7% vs 9.5%(p=0.09)。
- 总体队列及两个表现组中,标准化HLOS比值和风险校正HLOS均无TCC前后差异。
适用人群与场景
- 学术医学中心3个成人ICU的患者,TCC前(2016年1月至6月)2429例,TCC后(2017年1月至2019年6月)12479例。
- 低表现患者组定义为ICU入住时APACHE诊断类别在TCC前SMR>1.5,占TCC前12.6%(n=307)、TCC后13.3%(n=1671)。
- 其余患者为高表现组。
诊断标准与关键阈值
- 低表现患者组:ICU入住时APACHE诊断类别的TCC前SMR>1.5。
处置流程与药物剂量
- TCC实施包含 acuity 驱动的工作流程,靶向已识别的低表现患者组。
研究设计与关键结果
- 研究类型:前瞻性观察性前后对照研究;场所:学术医学中心3个成人ICU;TCC前2429例,TCC后12479例。
- 主要终点风险校正医院死亡率:总体ICU人群TCC前10.7% vs TCC后9.5%(p=0.09);低表现组26.4% vs 16.9%(p<0.001);高表现组8.5% vs 8.4%(p=0.86)。
- SMR:总体0.83 vs 0.75;低表现组1.61(95%CI 1.21-2.01)vs 1.03(95%CI 0.91-1.15);高表现组0.70(95%CI 0.59-0.81)vs 0.69(95%CI 0.64-0.73)。
- 标准化HLOS比值和风险校正HLOS在总体队列及两个表现组中均无TCC前后差异。
证据类型、等级与局限
- 证据类型:前瞻性观察性前后对照研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在人员充足且整体表现较高的学术医学中心ICU中,APACHE粒度可识别历史上表现较低的患者组,该组与TCC相关的SMR和风险校正死亡率下降显著。
- 本研究为TCC前表现与TCC后改善之间的关系提供了额外证据。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Studies evaluating telemedicine critical care (TCC) have shown mixed results. We prospectively evaluated the impact of TCC implementation on risk-adjusted mortality among patients stratified by pre-TCC performance.
DESIGN: Prospective, observational, before and after study.
SETTING: Three adult ICUs at an academic medical center.
PATIENTS: A total of 2,429 patients in the pre-TCC (January to June 2016) and 12,479 patients in the post-TCC (January 2017 to June 2019) periods.
INTERVENTIONS: TCC implementation which included an acuity-driven workflow targeting an identified "lower-performing" patient group, defined by ICU admission in an Acute Physiology and Chronic Health Evaluation diagnoses category with a pre-TCC standardized mortality ratio (SMR) of greater than 1.5.
MEASUREMENTS AND MAIN RESULTS: The primary outcome was risk-adjusted hospital mortality. Risk-adjusted hospital length of stay (HLOS) was also studied. The SMR for the overall ICU population was 0.83 pre-TCC and 0.75 post-TCC, with risk-adjusted mortalities of 10.7% and 9.5% (p = 0.09). In the identified lower-performing patient group, which accounted for 12.6% (n = 307) of pre-TCC and 13.3% (n = 1671) of post-TCC ICU patients, SMR decreased from 1.61 (95% CI, 1.21-2.01) pre-TCC to 1.03 (95% CI, 0.91-1.15) post-TCC, and risk-adjusted mortality decreased from 26.4% to 16.9% (p < 0.001). In the remaining ("higher-performing") patient group, there was no change in pre- versus post-TCC SMR (0.70 [0.59-0.81] vs 0.69 [0.64-0.73]) or risk-adjusted mortality (8.5% vs 8.4%, p = 0.86). There were no pre- to post-TCC differences in standardized HLOS ratio or risk-adjusted HLOS in the overall cohort or either performance group.
CONCLUSIONS: In well-staffed and overall higher-performing ICUs in an academic medical center, Acute Physiology and Chronic Health Evaluation granularity allowed identification of a historically lower-performing patient group that experienced a striking TCC-associated reduction in SMR and risk-adjusted mortality. This study provides additional evidence for the relationship between pre-TCC performance and post-TCC improvement.
参考来源
- Boyle WA, Palmer CM, Konzen L, et al. Telemedicine Critical Care-Mediated Mortality Reductions in Lower-Performing Patient Diagnosis Groups: A Prospective, Before and After Study. Crit Care Explor. 2023. PMID: 37753237. doi:10.1097/CCE.0000000000000979
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。